Key result
Alpha-2-blockade by rauwolscine (0.3 mg/kg) significantly attenuated the 10 Hz sympathetic-induced decline in coronary venous O2 saturation to 0.30±0.06 of control (p<0.001) under beta-blockade.
Why the study?
Postsynaptic alpha 2-adrenoceptors were implicated in sympathetic constriction of the poststenotic coronary bed despite being commonly regarded as noninnervated hormonal receptors. This study aimed to characterize the vascular alpha-adrenoceptor activated during competition between sympathetic constriction and metabolic dilation in the nonstenosed coronary bed.
Does alpha-2-adrenoceptor blockade with rauwolscine or alpha-1-adrenoceptor blockade with prazosin attenuate the sympathetic stimulation-induced decline in coronary venous oxygen saturation in open-chest dogs?
Does alpha-2-adrenoceptor blockade with rauwolscine or alpha-1-adrenoceptor blockade with prazosin attenuate the sympathetic stimulation-induced decline in coronary venous oxygen saturation in open-chest dogs?
Sympathetic constriction competing with metabolic dilation in the nonstenosed canine coronary bed is primarily mediated by activation of coronary vascular alpha-2-adrenoceptors rather than alpha-1-adrenoceptors.
Alpha-2 blockade attenuates sympathetic coronary constriction in dogs; leaves open relevance to human myocardial oxygen balance.
Recent observations on sympathetic constriction of the poststenotic coronary bed without dilatory reserve indicate the involvement of postsynaptic alpha 2-adrenoceptors, which are commonly regarded as noninnervated, hormonal receptors. Therefore, we characterized the vascular alpha-adrenoceptor activated during the competition between sympathetic constriction and metabolic dilation of the nonstenosed coronary bed by analyzing myocardial oxygen balance. In 39 anesthetized, spinalized open-chest dogs with bilateral cervical vagotomy, the left decentralized stellate ganglion was stimulated while mean aortic pressure was kept constant. Stimulation at 1 and 10 Hz lowered coronary venous oxygen saturation by 2.5 +/- 0.3 (SEM) and by 11.1 +/- 0.8 saturation %, respectively, in experiments under beta-blockade (4 mg/kg nadolol, n = 21). In experiments without beta-blockade (n = 18), the saturation response was similar. Under beta-blockade, alpha 2-blockade by rauwolscine (0.03 and 0.3 mg/kg) attenuated the decline in saturation induced by 10 Hz stimulation to 0.56 +/- 0.08 (p less than 0.01) of the control response and to 0.30 +/- 0.06 (p less than 0.001), respectively, whereas alpha 1-blockade by prazosin (0.012 and 0.12 mg/kg) modified this response only to 0.94 +/- 0.06 (NS) and to 0.75 +/- 0.08 (0.1 greater than p greater than 0.05). Without beta-blockade, similar attenuations to 0.36 +/- 0.07 (p less than 0.001) by 0.3 mg/kg rauwolscine and to 0.80 +/- 0.09 (NS) by 0.12 mg/kg prazosin were observed.(ABSTRACT TRUNCATED AT 250 WORDS)
No takes yet. Share an insight, caveat, or question.
Saeed et al. (1985) studied Sympathetic control of myocardial oxygen balance in nonstenosed coronary bed (n=39). Rauwolscine (alpha-2-blockade) vs Prazosin (alpha-1-blockade) during left stellate ganglion stimulation vs. Control response to 10 Hz left stellate ganglion stimulation was evaluated on Decline in coronary venous oxygen saturation induced by 10 Hz stellate ganglion stimulation (p=<0.001). Alpha-2-blockade by rauwolscine (0.3 mg/kg) significantly attenuated the 10 Hz sympathetic-induced decline in coronary venous O2 saturation to 0.30±0.06 of control (p<0.001) under beta-blockade.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: